Madrigal Pharmaceuticals (MDGL) PT Lowered to $131 at B.Riley
Tweet
Share
E-mailGet Alerts MDGL Hot Sheet
Price: $542.61 -0.79%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
B.Riley analyst Mayank Mamtani lowered the price target on Madrigal Pharmaceuticals (NASDAQ: MDGL) to $131.00 (from $174.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
- Obayashi Corporation (1802:JP) PT Lowered to JPY3,300 at Nomura/Instinet
- JPMorgan Downgrades ZTO Express Cayman (2057:HK) (ZTO) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
